Drug users' adherence to a 6-month vaccination protocol: Effects of motivational incentives

Drug and Alcohol Dependence

Volumn 107, Issue 1, 2010, Pages 76-79

  Stitzer, Maxine L ^a   Polk, Tiffany ^b   Bowles, Sarah ^a   Kosten, Thomas ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cocaine abuse; Contingency management; Medication adherence; Motivational incentives; Vaccines

Indexed keywords

HEPATITIS B VACCINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; COCAINE DEPENDENCE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; REWARD; VACCINATION;

ADOLESCENT; ADULT; COCAINE-RELATED DISORDERS; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATION; VACCINATION;

EID: 74749092928     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.09.006     Document Type: Article

References (20)

1. Bickel W.K., Marsch L.A., Buchhalter A.R., and Badger G.J. Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial. Exp. Clin. Psychopharm. 16 (2008) 132-143
2. Carroll K.M., Ball S.A., Nich C., O'Connor P.G., Eagan D.A., Frankforter T.L., Triffleman E.G., Shi J., and Rounsaville B.J. Targeting behavioral therapies to enhance Naltrexone treatment of opioid dependence. Arch. Gen. Psychiatry 58 (2001) 755-761
3. Centers for Disease Control and Prevention. Hepatitis B Vaccine: What You Need to Know (DHHS Publication No. 42 U.S.C. § 300aa-26) (2001), U.S. Gov. Printing Office, Atlanta, GA.
4. Comer S.D., Sullivan M.A., and Hulse G.K. Sustained-release naltrexone: novel treatment for opioid dependence. Expert Opin. Invest. Drugs 16 (2007) 1285-1294
5. Haney M., and Kosten T.R. Therapeutic vaccines for substance dependence. Expert Rev. Vaccines 3 (2004) 11-18
6. Johansson B.A., Berglund M., and Lindgren A. Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review. Addiction 101 (2006) 491-503
7. Kampman K.M. The search for medications to treat stimulant dependence. Addict. Sci. Clin. Pract. 4 (2008) 36-38
8. Malotte C.K., Hollingshead J.R., and Rhodes F. Monetary versus nonmonetary incentives for TB skin test reading among drug users. Am. J. Prev. Med. 16 (2001) 182-188
9. Martell B.A., Mitchell E., Poling J., Gonsal K., and Kosten T.R. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol. Psychiatry 58 (2005) 158-164
10. Mattick R.P., Kimber J., Breen C., and Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev. (2008) CD002207
11. Orson F.M., Kinsey B.M., Singh R.A., Wu Y., and Kosten T.R. Vaccines for cocaine abuse. Hum. Vaccine 5 (2009) 194-199
12. Petry N.M., and Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J. Consult. Clin. Psychol. 70 (2002) 398-405
13. Preston K.L., Silverman K., Umbricht A., DeJesus A., Montoya I.D., and Schuster C.R. Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend. 54 (1999) 127-135
14. Preti A. New Developments in the pharmacotherapy of cocaine abuse. Addict. Biol. 12 (2007) 133-151
15. Raisch D.W., Fye C.L., Boardman K.D., and Sather M.R. Opioid dependence treatment, including buprenorphine/naloxone. Ann. Pharmacother. 36 (2002) 312-321
16. Rigsby M.O., Rosen M.I., Beauvais J.E., Cramer J.A., Rainey P.M., O'Malley S.S., Dieckhaus K.D., and Rounsaville B.J. Cue dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J. Gen. Int. Med. 15 (2000) 841-847
17. Rosen M.J., Dieckhaus K., McMahon T.J., Valdes B., Petry N.M., Cramer J., and Rounsaville B. Improved adherence with contingency management. AIDS Patient Care STDS 21 (2007) 30-40
18. Seal K.H., Kral A.H., Lorvick J., McNees A., Gee L., and Edlin B.R. A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users. Drug Alcohol. Depend. 71 (2003) 127-131
19. Sigmon S.C., Wong C.J., Chausmer A.L., Liebson I.A., and Bigelow G.E. Evaluation of an injection depot formulation of buprenorphine: placebo comparison. Addiction 99 (2004) 1429-1449
20. Sorensen J.L., Haug N.A., Delucchi K.L., Gruber V., Kletter E., Batki S.L., Tulsky J.P., Barnett P., and Hall S. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 88 (2006) 54-63